Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging

Oncogene
K BlythM Stewart

Abstract

The Runx2 (Cbfa1, Pebp2alphaA, Aml3) gene was previously identified as a frequent target for transcriptional activation by proviral insertion in T-cell lymphomas of CD2-MYC transgenic mice. We have recently shown that over-expression of the full-length, most highly expressed Runx2 isoform in the thymus perturbs T-cell development, leads to development of spontaneous lymphomas at low frequency and is strongly synergistic with Myc. To gain further insight into the relationship of Runx2 to other lymphomagenic pathways, we tested the effect of combining the CD2-Runx2 transgene either with a Pim1 transgene (E(mu)-Pim1) or with the p53 null genotype, as each of these displays independent synergy with Myc. In both cases we observed synergistic tumour development. However, Runx2 appeared to have a dominant effect on the tumour phenotype in each case, with most tumours conforming to the CD3(+), CD8(+), CD4(+/-) phenotype seen in CD2-Runx2 mice. Neonatal infection of CD2-Runx2 mice with Moloney murine leukaemia virus (Moloney MLV) also led to a dramatic acceleration of tumour onset. Analysis of known Moloney MLV target genes in these lymphomas showed a high frequency of rearrangement at c-Myc or N-Myc (82%), and a significant number at P...Continue Reading

References

Feb 1, 1985·Genitourinary Medicine·G E RobinsonD Goldmeir
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·E OgawaY Ito
Jul 1, 1993·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M HarveyL A Donehower
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D J Fowlis, A Balmain
Apr 1, 1993·International Journal of Cancer. Journal International Du Cancer·M StewartJ C Neil
Apr 16, 1996·Proceedings of the National Academy of Sciences of the United States of America·Q WangN A Speck
Aug 5, 1997·Proceedings of the National Academy of Sciences of the United States of America·M StewartJ C Neil
Nov 11, 1998·Molecular Cell·J D LeversonS A Ness
Jun 23, 1999·Oncogene·G C Prendergast
Jun 23, 1999·Oncogene·C E NesbitE V Prochownik
Dec 28, 1999·Nature Genetics·J LiN G Copeland
Mar 14, 2000·Cell Death and Differentiation·E R CameronK Blyth
Jun 1, 2000·Nature·M HattoriUNKNOWN Chromosome 21 mapping and sequencing consortium

❮ Previous
Next ❯

Citations

Jul 21, 2004·Gene Expression Patterns : GEP·Maria Vega FloresShannon Fisher
May 7, 2003·Blood Cells, Molecules & Diseases·Ewan R CameronJames C Neil
May 17, 2002·Nature·Allan Balmain
Apr 2, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Linda ScobieJames C Neil
May 3, 2005·Nature Reviews. Cancer·Karen BlythJames C Neil
Feb 1, 2007·DNA and Cell Biology·Maya Kansara, David M Thomas
Oct 23, 2002·Molecular and Cellular Biology·Jennifer J WestendorfXiaodong Li
Mar 8, 2012·Molekuliarnaia biologiia·Iu N ZhukovaV N Danilenko
Jul 1, 2010·Cancer Research·Anna KilbeyJames C Neil
May 11, 2006·BMC Cell Biology·Teija L T AhoPäivi J Koskinen
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Daniel W YoungGary S Stein
Mar 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·L H CastillaP P Liu
Dec 14, 2006·Cancer Metastasis Reviews·J PratapG S Stein
Dec 11, 2014·Journal of Hematology & Oncology·Patrizia MondelloMichael Mian
Oct 9, 2012·Biochemical Pharmacology·Carmen Blanco-Aparicio, Amancio Carnero
Jun 29, 2010·Blood Cells, Molecules & Diseases·Karen BlythEwan R Cameron
Feb 16, 2005·American Journal of Medical Genetics. Part a·Johannes Hans M MerksRaoul C M Hennekam
Sep 24, 2004·International Journal of Cancer. Journal International Du Cancer·Ajay GoelC Richard Boland
Jul 12, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Jorge P PintoM Leonor Cancela
Jun 6, 2009·Journal of Cellular Biochemistry·Dario C AltieriGary S Stein
Oct 28, 2003·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Maggie L Kalev-ZylinskaKathryn E Crosier
Sep 4, 2008·Journal of Cellular Biochemistry·Hye-Ryun KimSuk-Chul Bae
Nov 22, 2012·Journal of Cellular Physiology·Nicola FerrariKaren Blyth
Nov 28, 2012·International Journal of Cancer. Journal International Du Cancer·Linda Shyue Huey ChuangYoshiaki Ito
May 18, 2013·Cancer Science·Kimiko ShimizuIssay Kitabayashi
Jan 27, 2011·Journal of Cellular Biochemistry·Nan HeL Darryl Quarles
Oct 16, 2009·American Journal of Medical Genetics. Part a·M Michael Cohen
Feb 5, 2004·Archives of Biochemistry and Biophysics·Myoung Seok KoJeong Woo Park
Jan 3, 2015·DNA and Cell Biology·Daniel WysokinskiJanusz Blasiak
Apr 16, 2004·Immunity·Nikolaus S TredeLeonard I Zon
Sep 25, 2010·Molecular Cancer·Sanjeev K BaniwalBaruch Frenkel
Oct 26, 2002·Cancer Cell·James C Neil, Ewan R Cameron

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.